Andrew Hore – Quoted Micro 10 May 2021
AQUIS STOCK EXCHANGE Virgata has published its offer document for the 50p a share bid for Walls & Futures REIT (WAFR) and the first acceptance date is 27 May. Walls & Future REIT management are still arguing that the bid is too low because it is at less than 50% of NAV. Virgata points out […]
Andrew Hore – Quoted Micro 29 March 2021
AQUIS STOCK EXCHANGE New Apex segment entry Samarkand (SMK) has got off to a strong start. At one point, shares were changing hands at 142p, against the placing price of 115p, but they ended the week at 123.5p (120p/127p). There was £15.4m raised after expenses. The company has developed e-commerce software technology known as Nomad. […]
Andrew Hore – Quoted Micro 8 February 2021
AQUIS STOCK EXCHANGE Clinical IT developer DXS International (DXSP) is encouraged by the initial results from pilots of the ExpertCare system designed to analyse the electronic records of people with hypertension. DXS is awaiting NHS accreditation. World High Life (LIFE) has appointed Tony Calamita as chief executive. He is a founder of Love Hemp, whose […]
Andrew Hore – Quoted Micro 25 January 2021
AQUIS STOCK EXCHANGE Rutherford Health (RUTH) has signed contracts with the NHS that underpin a significant proportion of its fixed costs. More cash will be required in order to take advantage of the potential for the cancer care clinics. The cash will be needed in the next few months and could be raised at the […]
Andrew Hore – Quoted Micro 18 January 2021
AQUIS STOCK EXCHANGE British Honey (BHC) generated revenues of £1.5m in the nine months to December 2020 with more sales online. There was £2.4m in the bank. Rutherford Health (RUTH) has agreed to provide cancer treatment to NHS Trusts and clinical commissioning groups in England. The initial agreement is for two years. A subsidiary of […]
Andrew Hore – Quoted Micro 14 December 2020
AQUIS STOCK EXCHANGE Incanthera (INC) says that study results for Sol, a sun cream that prevents skin cancer, have been better than expected. There is significantly greater dermal delivery by Sol compared with four rival products and it was found to be a non-irritant. The cream exceeds bioequivalence compared with oral treatments. A new patent […]
Andrew Hore – Quoted Micro 20 July 2020
AQUIS STOCK EXCHANGE In the year to February 2020, Rutherford Health (RUTH) nearly quadrupled its revenues from £1.47m to £5.61m, although the loss increased from £21.5m to £29.3m. There were three proton beam cancer treatment centres open at the end of the period, but two were not operating for long. They have continued to operate […]
Andrew Hore – Quoted Micro 6 July 2020
AQUIS STOCK EXCHANGE Rutherford Health (RUTH) has secured a diagnostics agreement with Somerset NHS Foundation Trust that is worth £19.1m over ten years, although it is initially for five years. Rutherford will supply imaging services from a facility in Taunton, which will be developed in partnership with Equitix. The service should start in the second […]
Andrew Hore – Quoted Micro 29 June 2020
AQUIS STOCK EXCHANGE Chapel Down Group (CDGP) increased sales last year, but the loss was also higher. Sales of wine and beer grew and revenues from continuing activities improved from £12.86m to £14.8m, while the loss more than doubled from £850,000 to £2.09m. the Chapel Down Gin Works in Kings Cross has been closed. There […]
Andrew Hore – Quoted Micro 25 May 2020
AQUIS STOCK EXCHANGE Daniel Thwaites (THW) closed its pubs and hotels on 20 May and it will not pay a final dividend for 2019-20. Net debt was £65.4m at the end of March 2020 and there are £16.6m of spare bank facilities. Trading had been strong, and the predominance of freehold properties means that rent […]